NURS 5433 MODULE 6 MSK EXAMINATION TEST 2026 DETAILED QUESTIONS AND SOLUTIONS GRADED A+

NURS 5433 MODULE 6 MSK EXAMINATION
TEST 2026 DETAILED QUESTIONS AND
SOLUTIONS GRADED A+

⩥ Low ICS. Answer: *Budesonide: 180-360 mcg/day (Pulmicort) and
Fluticasone propionate: 100-250 mcg/day (Flovent)


Beclomethasone: 80-160 mcg/day
Mometasone: 110 mcg/day


⩥ Medium ICS. Answer: • Budesonide: 361-720 mcg/day (Pulmicort )
• Fluticasone propionate: 251-500 mcg/day (Flovent )
• Beclomethasone: 161-320 mcg/day
• Mometasone: 220-440 mcg/day


⩥ High ICS. Answer: • Budesonide: >720 mcg/day (Pulmicort)
• Fluticasone propionate: >500 mcg/day (Flovent HFA)
• Beclomethasone: >320 mcg/day
• Mometasone: >440 mcg/day


⩥ SABA. Answer: Short-acting beta agonists such as salbutamol
(albuterol) and terbutaline.

, ⩥ LAMA. Answer: Long-acting muscarinic antagonists like tiotropium
and beclomethasone-formoterol glycopyrronium.


⩥ LABA. Answer: Long-acting beta agonists such as salmeterol and
formoterol.


⩥ ICS and LABA combo. Answer: Combination medications like
beclomethasone/formoterol and budesonide/formoterol.


⩥ SAMA. Answer: Short-acting muscarinic antagonists such as
ipratropium bromide and oxitropium bromide (combo with SABA).


⩥ Oral corticosteroids. Answer: Prednisone, prednisolone, and
methylprednisolone.


⩥ Anti-IgE. Answer: Omalizumab, a medication used for asthma
management.


⩥ Leukotriene modifiers (LTRA). Answer: Medications such as
montelukast, pranlukast, and zileuton.


⩥ Sustained step-up treatment. Answer: Increase treatment for at least 2-
3 months if symptoms persist despite controller treatment.